{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:26:38Z","timestamp":1753892798384,"version":"3.41.2"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>We investigated the associations of <jats:italic>DRD3<\/jats:italic> rs6280, <jats:italic>HTR1A<\/jats:italic> rs6295, <jats:italic>BDNF<\/jats:italic> rs6265, <jats:italic>SCL6A4<\/jats:italic> rs16965628, and <jats:italic>5HT2A<\/jats:italic> rs7322347 with schizophrenia in a case\u2013control study, and associations of these genetic variants with several clinical features. We also investigated markers of inflammatory response (C-reactive protein, IL-2, IL-6, IL-10), the activity of leukocytic elastase (LE) and \u03b11-proteinase inhibitor (a1-PI), antibodies to S100B and myelin basic protein (MBP) in schizophrenia. Clinical symptoms were assessed on three scales: Positive and Negative Syndrome Scale, The Bush \u2013 Francis Catatonia Rating Scale and Frontal Assessment Battery. All SNPs were typed using predesigned TaqMan SNP genotyping assays. The biomarkers related to the immune system were routinely tested using ELISA kits. The association with schizophrenia was found for <jats:italic>DRD3<\/jats:italic> rs6280 (<jats:italic>p<\/jats:italic> = 0.05) and <jats:italic>HTR2A<\/jats:italic> rs7322347 (<jats:italic>p<\/jats:italic> = 0.0013). We found differences between groups by parameters of LE and a1-PI and LE\/a1-PI (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). And IL-6 was evaluated in the schizophrenia group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). We showed that patients with the TT allele (<jats:italic>BDNF<\/jats:italic> rs6265) had more severe impairments in frontal lobe function. a1-PI can serve as a marker for assessing the severity of frontal lobe damage in patients with frontal dementia. We found some biological parameters reflecting the severity of frontal dysfunction in schizophrenia.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.655178","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T16:45:14Z","timestamp":1620405914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia"],"prefix":"10.3389","volume":"12","author":[{"given":"Anna","family":"Morozova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Zorkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantine","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Abramova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Ushakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Mudrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Zozulya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Otman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoya","family":"Sarmanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Klyushnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgiy","family":"Kostyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Chekhonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1176\/appi.ajp.2014.14040435","article-title":"Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies","volume":"172","author":"Arnedo","year":"2015","journal-title":"Am J Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.schres.2017.10.037","article-title":"The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: systematic review","volume":"197","author":"Mistry","year":"2018","journal-title":"Schizophrenia Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/mp.2015.16","article-title":"Evaluating historical candidate genes for schizophrenia","volume":"20","author":"Farrell","year":"2015","journal-title":"Mol Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature12975","article-title":"A polygenic burden of rare disruptive mutations in schizophrenia","volume":"506","author":"Purcell","year":"2014","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrg3240","article-title":"Genetic architectures of psychiatric disorders: the emerging picture and its implications","volume":"13","author":"Sullivan","year":"2012","journal-title":"Nat Rev Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1073\/pnas.0508189103","article-title":"A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor","volume":"103","author":"Jeanneteau","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e54108","DOI":"10.1371\/journal.pone.0054108","article-title":"The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement","volume":"8","author":"Savitz","year":"2013","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"pyv125","DOI":"10.1093\/ijnp\/pyv125","article-title":"HTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: a meta-analysis","volume":"19","author":"Takekita","year":"2016","journal-title":"Int J Neuropsychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12325-010-0035-4","article-title":"Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia","volume":"27","author":"Sumiyoshi","year":"2010","journal-title":"Adv Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41397-019-0101-5","article-title":"A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs","volume":"20","author":"Yoshikawa","year":"2020","journal-title":"Pharmacogenom J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1176\/ajp.156.1.72","article-title":"Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects","volume":"156","author":"Lewis","year":"1999","journal-title":"Am J Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2174\/092986707781368450","article-title":"HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies","volume":"14","author":"Serretti","year":"2007","journal-title":"Curr Med Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12863-015-0325-6","article-title":"Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons","volume":"17","author":"Ruble","year":"2016","journal-title":"BMC Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fpsyt.2019.00830","article-title":"Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A with clinical features of youth-onset schizophrenia","volume":"10","author":"Morozova","year":"2019","journal-title":"Front Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fpsyt.2013.00045","article-title":"BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory","volume":"4","author":"Nieto","year":"2013","journal-title":"Front Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/YPG.0b013e328360c866","article-title":"BDNF Val66Met polymorphism and anxiety\/depression symptoms in schizophrenia in a Chinese Han population","volume":"23","author":"Sun","year":"2013","journal-title":"Psychiatr Genet."},{"key":"B19","first-page":"1617","article-title":"Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia","volume":"6","author":"Zhai","year":"2013","journal-title":"Int J Clin Exp Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1176\/appi.neuropsych.11100234","article-title":"BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population","volume":"25","author":"Suchanek","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41386-018-0248-9","article-title":"Effects of BDNF Val66Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans","volume":"44","author":"Schweiger","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neuropharm.2008.08.034","article-title":"How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems","volume":"55","author":"Murphy","year":"2008","journal-title":"Neuropharmacology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1744-9081-8-24","article-title":"Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia","volume":"8","author":"Lindholm Carlstr\u00f6m","year":"2012","journal-title":"Behav Brain Funct."},{"key":"B24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/gtmb.2014.0319","article-title":"Genetic polymorphism of the serotonin transporter gene, SLC6A4 rs16965628, is associated with obsessive compulsive disorder","volume":"19","author":"Cengiz","year":"2015","journal-title":"Genet Testing Mol Biomark."},{"key":"B25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12291-008-0071-x","article-title":"The biochemical womb of schizophrenia: a review","volume":"23","author":"Gaur","year":"2008","journal-title":"Indian J Clin Biochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1017\/S095457941500019X","article-title":"Dysplasticity, metaplasticity, and schizophrenia: implications for risk, illness, novel interventions","volume":"27","author":"Keshavan","year":"2015","journal-title":"Dev Psychopathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fpsyt.2020.00160","article-title":"The role of inflammation in the treatment of schizophrenia","volume":"11","author":"Fond","year":"2020","journal-title":"Front Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","article-title":"Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms","volume":"41","author":"Stojanovic","year":"2014","journal-title":"Psychoneuroendocrinology."},{"key":"B31","first-page":"S242","article-title":"Interleukin-6 and cognition in non-affective psychosis","volume":"39","author":"Miller","year":"2013","journal-title":"Schizophr Bull."},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.schres.2017.04.015","article-title":"Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review","volume":"192","author":"Misiak","year":"2018","journal-title":"Schizophrenia Res."},{"key":"B33","first-page":"37","article-title":"Immunological monitoring of endogenous paroxysmal psychoses","volume":"114","author":"Klyushnik","year":"2014","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova."},{"key":"B34","first-page":"5","article-title":"Clinico-psychopathological and immunological parameters of manic-delusional (including manic-paraphrenic) conditions with grandiose delusion","volume":"29","author":"Zozulya","year":"2019","journal-title":"Soc Clin Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.nbd.2009.04.006","article-title":"Neutrophil elastase and neurovascular injury following focal stroke and reperfusion","volume":"35","author":"Stowe","year":"2009","journal-title":"Neurobiol Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0006-8993(99)02431-2","article-title":"Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion","volume":"858","author":"Shimakura","year":"2000","journal-title":"Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00005-012-0162-5","article-title":"Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent","volume":"60","author":"Bergin","year":"2012","journal-title":"Arch Immunol Ther Exp."},{"key":"B38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fphar.2018.00341","article-title":"The multifaceted effects of alpha1-antitrypsin on neutrophil functions","volume":"9","author":"Janciauskiene","year":"2018","journal-title":"Front Pharmacol."},{"key":"B39","first-page":"F76","article-title":"S100B in schizophrenia: an update","volume":"28","author":"Rothermundt","year":"2009","journal-title":"Gen Physiol Biophys."},{"key":"B40","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.psychres.2017.09.041","article-title":"Cognitive deficit in patients with paranoid schizophrenia: its clinical and laboratory correlates","volume":"262","author":"Dorofeikova","year":"2018","journal-title":"Psychiatry Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1017\/S0033291719001685","article-title":"Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis","volume":"49","author":"Bora","year":"2019","journal-title":"Psychol Med."},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1111\/eip.13063","article-title":"Sex differences in social functioning of patients with schizophrenia depending on the age of onset and severity of the disease","volume-title":"Early Interv Psychiatry.","author":"Zorkina","year":"2020"},{"key":"B43","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am J Psychiatry."},{"key":"B44","first-page":"20","article-title":"Detection of leukocyte elastase from complexes with plasmin inhibitor by its enzymatic activity with a synthetic substrate","volume":"40","author":"Dotsenko","year":"1994","journal-title":"Vopr Med Khimii."},{"key":"B45","first-page":"494","article-title":"A unified method for assay of alpha-1-antitrypsin and alpha-2-macroglobulin activity in human serum (plasma)","volume":"25","author":"Nartikova","year":"1979","journal-title":"Vopr Med Khimii."},{"key":"B46","first-page":"32c","article-title":"Laboratory diagnostics in monitoring patients with endogenous psychoses \u201cNeuro-immuno-test","volume-title":"Medical technology","author":"Klyushnik","year":"2016"},{"key":"B47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000339456","article-title":"Motor symptoms and schizophrenia","volume":"66","author":"Walther","year":"2012","journal-title":"Neuropsychobiology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/schbul\/sbp059","article-title":"Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature","volume":"36","author":"Fink","year":"2010","journal-title":"Schizophrenia Bull."},{"key":"B49","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jpsychires.2005.11.004","article-title":"Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients","volume":"40","author":"Huang","year":"2006","journal-title":"J Psychiatr Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4172\/Neuropsychiatry.1000300","article-title":"Proteome analysis of catatonia","volume":"7","author":"Huang","year":"2017","journal-title":"Neuropsychiatry."},{"key":"B51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bj.2020.01.001","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fpsyt.2018.00129","article-title":"Distinct associations of motor domains in relatives of schizophrenia patients-different pathways to motor abnormalities in schizophrenia?","volume":"9","author":"Sch\u00e4ppi","year":"2018","journal-title":"Front Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1011","DOI":"10.4088\/JCP.15m10269","article-title":"BDNF polymorphisms are associated with cognitive performance in schizophrenia patients versus healthy controls","volume":"77","author":"Zhang","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yebeh.2015.11.013","article-title":"NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy","volume":"54","author":"Warburton","year":"2016","journal-title":"Epilepsy Behav."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10434","DOI":"10.1002\/jcb.28328","article-title":"Functional rs6265 polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in posttraumatic stress disorder among Chinese patients with hepatocellular carcinoma","volume":"120","author":"Guo","year":"2019","journal-title":"J Cell Biochem."},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1080\/23279095.2020.1830774","article-title":"BDNF (rs6265) Val < Met polymorphism can buffer cognitive functions against post stroke CT\/MRI pathological findings","volume-title":"Appl Neuropsychol. Adult","author":"Rezaei","year":"2020"},{"key":"B57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.9758\/cpn.2016.14.3.270","article-title":"Gender-specific associations of the brain-derived neurotrophic factor Val66Met polymorphism with neurocognitive and clinical features in schizophrenia","volume":"14","author":"Kim","year":"2016","journal-title":"Clin Psychopharmacol Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.4088\/JCP.13m08772","article-title":"Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration","volume":"75","author":"Xiong","year":"2014","journal-title":"J Clin Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.euroneuro.2015.09.013","article-title":"Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-na\u00efve patients with first-episode psychosis","volume":"25","author":"Ota","year":"2015","journal-title":"Eur Neuropsychopharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/14737159.2018.1438192","article-title":"Alpha-1-antitrypsin: a novel predictor for long-term recovery of chronic disorder of consciousness","volume":"18","author":"Bao","year":"2018","journal-title":"Expert Rev Mol Diagnos."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.cub.2018.05.025","article-title":"Differential role of prefrontal and parietal cortices in controlling level of consciousness","volume":"28","author":"Pal","year":"2018","journal-title":"Curr Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cortex.2017.02.011","article-title":"Abnormal structural connectivity between the basal ganglia, thalamus, and frontal cortex in patients with disorders of consciousness","volume":"90","author":"Weng","year":"2017","journal-title":"Cortex."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.3389\/fpsyg.2019.02968","article-title":"The common basis of memory and consciousness: understanding the brain as a write-read head interacting with an omnipresent background field","volume":"10","author":"Keppler","year":"2020","journal-title":"Front Psychol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17116\/jnevro202012006246","article-title":"Osobennosti immunnogo profilya bol'nykh shizofreniei s katatonicheskim sindromom. Features of the immune profile of schizophrenic patients with catatonic syndrome","volume":"120","author":"Zakharova","year":"2020","journal-title":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.655178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T16:45:33Z","timestamp":1620405933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.655178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":64,"alternative-id":["10.3389\/fpsyt.2021.655178"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.655178","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"article-number":"655178"}}